Log in

NASDAQ:MRNSMarinus Pharmaceuticals Insider Trades

$1.82
-0.01 (-0.55 %)
(As of 08/11/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.74
Now: $1.82
$1.90
50-Day Range
$1.59
MA: $2.14
$2.74
52-Week Range
$1.01
Now: $1.82
$3.50
Volume1.62 million shs
Average Volume1.26 million shs
Market Capitalization$222.39 million
P/E RatioN/A
Dividend YieldN/A
Beta2.04

Insider Trades

Marinus Pharmaceuticals (NASDAQ:MRNS) Insider Buying and Selling Activity

Insider Ownership Percentage: 2.80%

Insider Buying and Selling by Quarter


Marinus Pharmaceuticals (NASDAQ MRNS) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/30/2020Edward F SmithCFOSell2,380$2.05$4,879.0017,717  
12/13/2019Scott BraunsteinCEOBuy100,000$1.62$162,000.00
5/16/2019Edward F SmithCFOSell24,211$5.03$121,781.3320,097  
1/29/2019Edward F SmithCFOSell2,492$3.06$7,625.5244,308  
1/28/2019Christopher Michael CashmanCEOSell8,142$3.13$25,484.46239,761  
1/29/2018Edward F SmithCFOSell3,000$7.91$23,730.0049,800  
1/18/2018Christopher Michael CashmanCEOSell9,566$6.28$60,074.48247,903  
12/19/2017Bain Capital Life Sciences InvMajor ShareholderSell1,272,547$7.88$10,027,670.36  
12/15/2017Bain Capital Life Sciences InvMajor ShareholderSell822,547$8.10$6,662,630.70  
10/20/2016Anand MehraMajor ShareholderSell750,683$1.39$1,043,449.37  
8/8/2016Vii Lp CanaanMajor ShareholderSell149,154$1.50$223,731.00  
8/4/2016Vii Lp CanaanMajor ShareholderSell145,583$1.50$218,374.50  
7/29/2016Vii Lp CanaanMajor ShareholderSell24,540$1.71$41,963.40  
7/27/2016Vii Lp CanaanMajor ShareholderSell20,589$1.81$37,266.09  
7/26/2016Vii Lp CanaanMajor ShareholderSell20,380$1.81$36,887.80  
7/25/2016Vii Lp CanaanMajor ShareholderSell270,750$1.90$514,425.00  
4/21/2015Gail M FarfelInsiderSell30,000$9.48$284,400.00  
8/5/2014Domain Partners Vi, L.P.Major ShareholderBuy419,744$8.00$3,357,952.00  
8/5/2014Stephen M BlochDirectorBuy625,000$8.00$5,000,000.00  
(Data available from 1/1/2013 forward)
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.